Chenyang Guo
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Surgery 13
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
- Esophageal and GI Pathology 4
- Co-authors
- Zheng Lin (9 shared papers)Hai-Liang Li (17 shared papers)Shun Tang (1 shared paper)Hui Zhao (1 shared paper)Haibo Xu (1 shared paper)Tao Qiu (1 shared paper)Shan Ren (1 shared paper)Han Yang (1 shared paper)
- Journals
- Frontiers in Oncology (5 papers)Oncotarget (3 papers)Cancer Management and Research (2 papers)Advanced Functional Materials (2 papers)Digestive and Liver Disease (1 paper)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Chenyang Guo
34 papers receiving 496 citations
Chenyang Guo's Hit Papers
Peers
Comparison fields: 5 of 92
- Hepatology 175
- Cancer Research 58
- Food Science 65
- Pathology and Forensic Medicine 53
- Pharmacology 24
Countries citing papers authored by Chenyang Guo
This map shows the geographic impact of Chenyang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyang Guo more than expected).
Fields of papers citing papers by Chenyang Guo
This network shows the impact of papers produced by Chenyang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyang Guo. The network helps show where Chenyang Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenyang Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Peppermint essential oil: its phytochemistry, biological activity, pharmacological effect and application Hit paper breakdown → | 2022 | 136 |
| 2 | 2014 | 59 | |
| 3 | 2018 | 34 | |
| 4 | 2016 | 33 | |
| 5 | 2023 | 27 | |
| 6 | 2017 | 26 | |
| 7 | 2024 | 19 | |
| 8 | 2018 | 16 | |
| 9 | 2022 | 15 | |
| 10 | 2024 | 13 | |
| 11 | 2024 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2015 | 10 | |
| 14 | 2018 | 9 | |
| 15 | 2018 | 9 | |
| 16 | 2017 | 9 | |
| 17 | 2022 | 7 | |
| 18 | 2023 | 7 | |
| 19 | [The clinical therapeutic effects of arsenic trioxide combined with transcatheter arterial chemoembolization in treating primary liver cancer with pulmonary metastases]. | 2012 | 7 |
| 20 | 2022 | 6 |
About Chenyang Guo
Chenyang Guo is a scholar working on Hepatology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 38 papers that have together received 502 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer, Hypoxia, and Metabolism (5 papers), Renal cell carcinoma treatment (4 papers), Esophageal and GI Pathology (4 papers), Cancer Mechanisms and Therapy (3 papers), Lung Cancer Research Studies (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (175 citations), Cancer Research (58 citations), Food Science (65 citations), Pathology and Forensic Medicine (53 citations) and Pharmacology (24 citations). Chenyang Guo has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Zheng Lin, Hai-Liang Li, Shun Tang, Hui Zhao, Haibo Xu, Tao Qiu, Shan Ren, Han Yang, Maolun Liu and Tianqi Ming. Their work appears in journals such as Frontiers in Oncology, Oncotarget, Cancer Management and Research, Advanced Functional Materials and Digestive and Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.